Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $69.03 million. The enterprise value is -$150.44 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRBU has 93.00 million shares outstanding. The number of shares has increased by 22.37% in one year.
| Current Share Class | 93.00M |
| Shares Outstanding | 93.00M |
| Shares Change (YoY) | +22.37% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 4.70% |
| Owned by Institutions (%) | 62.76% |
| Float | 83.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.04 |
| Forward PS | 7.10 |
| PB Ratio | 0.28 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.16, with a Debt / Equity ratio of 0.10.
| Current Ratio | 7.16 |
| Quick Ratio | 6.94 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -47.99% and return on invested capital (ROIC) is -30.02%.
| Return on Equity (ROE) | -47.99% |
| Return on Assets (ROA) | -27.18% |
| Return on Invested Capital (ROIC) | -30.02% |
| Return on Capital Employed (ROCE) | -57.35% |
| Revenue Per Employee | $67,986 |
| Profits Per Employee | -$1.01M |
| Employee Count | 147 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.80% in the last 52 weeks. The beta is 2.36, so CRBU's price volatility has been higher than the market average.
| Beta (5Y) | 2.36 |
| 52-Week Price Change | -81.80% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.74 |
| Relative Strength Index (RSI) | 34.20 |
| Average Volume (20 Days) | 1,042,035 |
Short Selling Information
The latest short interest is 9.89 million, so 10.63% of the outstanding shares have been sold short.
| Short Interest | 9.89M |
| Short Previous Month | 8.82M |
| Short % of Shares Out | 10.63% |
| Short % of Float | 11.78% |
| Short Ratio (days to cover) | 9.66 |
Income Statement
In the last 12 months, CRBU had revenue of $9.99 million and -$149.11 million in losses. Loss per share was -$1.65.
| Revenue | 9.99M |
| Gross Profit | -119.56M |
| Operating Income | -162.12M |
| Pretax Income | -123.25M |
| Net Income | -149.11M |
| EBITDA | -158.19M |
| EBIT | -162.12M |
| Loss Per Share | -$1.65 |
Full Income StatementBalance Sheet
The company has $209.54 million in cash and $26.49 million in debt, giving a net cash position of $222.90 million or $2.40 per share.
| Cash & Cash Equivalents | 209.54M |
| Total Debt | 26.49M |
| Net Cash | 222.90M |
| Net Cash Per Share | $2.40 |
| Equity (Book Value) | 252.95M |
| Book Value Per Share | 2.74 |
| Working Capital | 188.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$138.20 million and capital expenditures -$4.88 million, giving a free cash flow of -$143.08 million.
| Operating Cash Flow | -138.20M |
| Capital Expenditures | -4.88M |
| Free Cash Flow | -143.08M |
| FCF Per Share | -$1.54 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,622.13% |
| Pretax Margin | -1,492.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |